Coexistence of CADASIL and Alzheimer's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 6, 2003, Pages 790-792

  Thijs, Vincent ^a,b   Robberecht, W ^a   De Vos, R ^b   Sciot, R ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; NOTCH RECEPTOR; PRESENILIN 1; PRESENILIN 2;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN INFARCTION; CASE REPORT; CEREBROVASCULAR DISEASE; COMORBIDITY; DISEASE ASSOCIATION; HUMAN; LEUKOENCEPHALOPATHY; MALE; NEUROFIBRILLARY TANGLE; POINT MUTATION; PRIORITY JOURNAL; SENILE PLAQUE; SYNDROME CADASIL;

ALZHEIMER DISEASE; BRAIN; CEREBRAL INFARCTION; DEMENTIA, MULTI-INFARCT; DNA MUTATIONAL ANALYSIS; EXONS; FATAL OUTCOME; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEUROFIBRILLARY TANGLES; POINT MUTATION; RECEPTORS, NOTCH;

EID: 0038692431     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.6.790     Document Type: Article

References (13)

1. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-10.
2. Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998;44:731-9.
3. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284:770-6.
4. De Strooper B, Annaert W, Cupers P, et al. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 1999;398:518-22.
5. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-59.
6. Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 1997;350:1511-15.
7. Baudrimont M, Dubas F, Joutel A, et al. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke 1993;24:122-5.
8. Kawas C, Gray S, Brookmeyer R, et al. Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 2000;54:2072-7.
9. Haroutunian V, Purohit DP, Perl DP, et al. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol 1999;56:713-18.
10. Gray F, Robert F, Labrecque R, et al. Autosomal dominant arteriopathic leuko-encephalopathy and Alzheimer's disease. Neuropathol Appl Neurobiol 1994;20:22-30.
11. Joutel A, Andreux F, Gaulis S, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 2000;105:597-605.
12. Mohr JP. CADASIL and white matter syndromes. Ann Neurol 1998;44:715-16.
13. Joutel A, Favrole P, Labauge P, et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet 2001;358:2049-51.